Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Filings indexed 1,096 across all filing types
Latest filing 2020-03-25 Regulatory Filings
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
8-K/A
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, which is a current report used to disclose unscheduled material events or corporate changes. It amends a previously filed Form 8-K to update information about the financial impact of a divestiture and asset impairment. The document does not contain comprehensive financial statements or detailed financial analysis typical of Annual Reports (10-K) or Interim Reports (IR). It is not a transcript, proxy, or governance document. The content focuses on reporting a specific event and its financial impact, consistent with the purpose of a current report amendment. Therefore, the filing type is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2020-03-25 English
SC 13D/A
Major Shareholding Notification
2020-03-03 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Landec Corporation. It includes a press release announcing the company's plan to explore strategic alternatives for a business segment and provides updated fiscal year 2020 guidance. The document also announces a conference call for investors. The content is typical of a current report (8-K) which is used to disclose material events or corporate changes that shareholders should know about between periodic reports. It is not a full annual or quarterly report, nor is it an earnings release or management discussion. It is not a proxy, audit, or legal filing. The presence of a press release and conference call announcement within the 8-K confirms it is a current report filing. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like 8-Ks that do not fit other categories.
2020-02-27 English
8-K/A
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, which is a current report used to disclose material events or corporate changes. The content includes modifications to performance criteria for cash bonuses, approval of a new stock incentive plan, and related disclosures. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or quarterly reports. It also does not fit categories like earnings release, management reports, or governance information. The document is an amendment to a current report, which is a regulatory filing to update or correct previously filed information. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-02-27 English
FORM SC 13G
Major Shareholding Notification
2020-02-12 English
SCHEDULE 13G/A
Major Shareholding Notification
2020-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.